Insight

Rafeh Naqash: Important data in the field of toxicities

Photo from Rafeh Naqash/Twitter

Nov 27, 2023, 16:52

Rafeh Naqash: Important data in the field of toxicities

Quoting Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center, on X/Twitter:

”Hot off the press now in The Lancet Oncology, led by Yu Fujiwara with an excellent team Amin Nassar, Elio Adib, Zain Ul Abideen Asad, Nobuyuki Horita and Susu Zhou. Thank you The Lancet Oncology teams for the editorial support. OU Health Stephenson Cancer Center, Sarah Cannon Docs. Also read commentary!!

Important data in the field of toxicities balancing risk vs benefit and encouraging NEED for multi D care of these individuals getting immunotherapy in the earlier stage setting!”

For the article click here.
Source: Rafeh Naqash/Twitter

Amin Nassar cancer Elio Adib Immune Checkpoint Inhibitors immunotherapy OncoDaily Oncology OU Health Stephenson Cancer Center Rafeh Naqash Sarah Cannon Docs The Lancet Oncology Yu Fujiwara Zain Ul Abideen Asad

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage